改良翼点入路显微切除鞍结节脑膜瘤

目的 总结经改良翼点入路显微手术切除鞍结节脑膜瘤的经验. 方法回顾性分析广州军区武汉总医院神经外科自2001年1月至2007年4月应用改良翼点入路显微手术治疗的26例鞍结节脑膜瘤患者的临床资料. 结果 26例患者获Simpson Ⅰ级切除11例,Ⅱ级切除14例,Ⅲ级切除1例.术后视力损害和视野缺损均有不同程度恢复23例,1例视力无改变,术后视力下降2例经治疗后改善.7例术后出现不同程度的尿崩,经对症治疗约10 d后好转.无1例死亡.随访6个月～5年,肿瘤无复发. 结论改良翼点入路可对中颅窝、前颅窝、鞍区及鞍旁病变进行良好暴露,能处理各种类型的鞍结节脑膜瘤,提高全切除率,减少术后并发症,值得临床推广应用.

Modified transpterygoid approach for microsurgical removal of tuberculum sellae meningiomas

Objective To summarize the experience with modified transpterygoid craniotomy for microsurgical resection of tuberculum sellae meningiomas. Methods The clinical data were retrospectively analyzed in 26 patients with tuberculum sellae meningiomas admitted between January, 2001 and April, 2007 in our hospital to receive microsurgical meningioma removal using a modified transpterional approach. The basal part of the tumor was firstly coagulated and dissected to control the blood supply of the lesion. Through the cerebral cisterns in the sellar region and the interfaces between the tumor and the adjacent structures, the tumor was removed to the greatest possible extent with minimal invasiveness to the neighboring structures. Results Simpson grade Ⅰ resection was achieved in 11 patients, grade Ⅱ resection in 14 patients, and grade Ⅲ resection in 1 patient. The visual acuity and the optic field were improved in 23 patients, and remained unchanged in 1 patient after the operation. Two patients had postoperative visual acuity deterioration, which was improved after appropriate treatment. Seven patients developed diabetes insipidus after the operation, and gradually recovered after symptomatic treatments for about 10 days without fatal consequences. Follow-up for 6 months to 5 years found no recurrence of meningiomas in these patients. Conclusions The modified transpterional approach provides excellent exposure of the middle fossa, anterior cranial fossa, saddle and parasellar areas, and is effective for different types of tuberculum seilae meningiomas with increased total resection rate and reduced postoperative complications.